Literature DB >> 8948414

Long-term control of prostate cancer with radiation. Past, present, and future.

G E Hanks1.   

Abstract

This article details the methods of determining cancer-free status and addresses the long-term results of external beam radiation. It demonstrates that when similar patients are compared, the results of prostatectomy and radiation in early disease do not differ. The new technology in conformal radiation produces outcomes superior to conventional radiation technique in cure of cancer and reduction of serious complications.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8948414     DOI： 10.1016/s0094-0143(05)70339-6

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  9 in total

1.  Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo.

Authors:  Jisun Lee; Seul Lee; Andriy Synytsya; Peter Capek; Chang Won Lee; Ji Won Choi; Sarang Cho; Woo Jung Kim; Yong Il Park
Journal:  Mar Biotechnol (NY)       Date:  2018-08-29       Impact factor: 3.619

2.  Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.

Authors:  D Deeb; X Gao; H Jiang; A S Arbab; S A Dulchavsky; S C Gautam
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

3.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

Authors:  Dorrah Deeb; Xiaohua Gao; Hao Jiang; Scott A Dulchavsky; Subhash C Gautam
Journal:  Prostate       Date:  2009-06-01       Impact factor: 4.104

4.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.

Authors:  Dorrah Deeb; Xiaohua Gao; Hao Jiang; Branislava Janic; Ali S Arbab; Yon Rojanasakul; Scott A Dulchavsky; Subhash C Gautam
Journal:  Biochem Pharmacol       Date:  2009-09-24       Impact factor: 5.858

5.  Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.

Authors:  Yong Bo Liu; Xiaohua Gao; Dorrah Deeb; Ali S Arbab; Subhash C Gautam
Journal:  J Carcinog Mutagen       Date:  2013-11-05

6.  Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.

Authors:  Xiaohua Gao; Dorrah Deeb; Yongbo Liu; Ali S Arbab; George W Divine; Scott A Dulchavsky; Subhash C Gautam
Journal:  Cancers (Basel)       Date:  2011       Impact factor: 6.639

7.  Incidence of genitourinary complications following radiation therapy for localised prostate cancer.

Authors:  Rowan V David; Arman A Kahokehr; Jason Lee; David I Watson; John Leung; Michael E O'Callaghan
Journal:  World J Urol       Date:  2022-08-11       Impact factor: 3.661

Review 8.  Long-term results after external beam radiation therapy for T1-T2 localized prostate cancer.

Authors:  B W Lagerveld; M P Laguna; J J M C H de la Rosette
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

9.  Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin.

Authors:  Yong Bo Liu; Xiaohua Gao; Dorrah Deeb; Chris Brigolin; Yiguan Zhang; Jiajiu Shaw; Kirit Pindolia; Subhash C Gautam
Journal:  Int J Oncol       Date:  2014-07-25       Impact factor: 5.650
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.